| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |